Skip to main content
Clinical Trials/NCT05179109
NCT05179109
Recruiting
Not Applicable

Robotic Versus Laparoscopic Surgery for Severe Deep Endometriosis: a Prospective, Randomized, Controlled Trial

University of Oulu1 site in 1 country70 target enrollmentOctober 3, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Endometriosis
Sponsor
University of Oulu
Enrollment
70
Locations
1
Primary Endpoint
NRS (Numeric rating scale) Score for pain
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The objective of this study is to examine whether robot-assisted laparoscopy is superior compared to conventional laparoscopy as regards to patient outcome.

Detailed Description

The objective of this prospective, randomized trial is to examine whether robot-assisted laparoscopy is superior compared to conventional laparoscopy as regards to patient outcome at 6, 12 and 24 months postoperatively, measured by questionnaires concerning the pain symptoms and disease-related quality-of life.

Registry
clinicaltrials.gov
Start Date
October 3, 2022
End Date
December 31, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sari Koivurova

Assistant Chief of Gynecology

University of Oulu

Eligibility Criteria

Inclusion Criteria

  • ASA (American Society of Anesthesiologists physical status classification) 1-3
  • Diagnosed deep endometriosis (MRI)
  • Patient has symptoms
  • Operative treatment is indicated
  • Patient is able to give informed consent

Exclusion Criteria

  • Recurring rectosigmoid endometriosis

Outcomes

Primary Outcomes

NRS (Numeric rating scale) Score for pain

Time Frame: Immediately postoperatively (24 hours) and 6, 12 and 24 months postoperatively

The surgical outcome as regards to pain symptoms (NRS questionnaire), absolute scores and change from baseline for both study groups.

Secondary Outcomes

  • Endometriosis-related quality-of-life(6, 12 and 24 months)
  • Intraoperative measures(Up to 300 minutes (intraoperative))
  • Sexual quality-of-life questionnaire(6, 12 and 24 months)
  • General 15 dimensional health-related quality-of-life questionnaire(6, 12 and 24 months)
  • Factors concerning ERAS (Enhanced recovery after surgery)(Up to 7 days (Hospital stay))
  • Cost(Primary hospital stay and 24 months, for both study groups.)
  • Complications(30 days)

Study Sites (1)

Loading locations...

Similar Trials